EIR Frontida BioPharm Mar 2005

Thomas Friel FDA$595.00 - Available Now

FDA investigators audited the Frontida BioPharm - Philadelphia, PA, United States facility and issued inspectional observation (via FDA 483) on 02 Mar 2005.

Product details

  • Category:
  • Inspection end: 02 Mar 2005
  • Location: Philadelphia, United States
  • FEI: 2523348
Add To Cart